What Happens When the Heart Starts to Fibrillate?

When a heart fibrillates, its muscle fibers stop contracting in the coordinated, rhythmic squeezes that pump blood and instead quiver chaotically, with different patches of tissue firing electrical impulses on their own schedules. The result looks less like a beating heart and more like a bag of worms wriggling independently. Whether this happens in the upper chambers (atria) or the lower chambers (ventricles) makes an enormous difference in how dangerous it is, but the core problem is the same: the heart’s electrical signals fragment into multiple competing wavefronts that circle and collide instead of sweeping neatly from top to bottom.

What Normally Keeps the Heart in Rhythm

A healthy heartbeat starts in a small cluster of cells in the right atrium called the sinus node, which fires an electrical impulse roughly once per second at rest. That impulse spreads across both atria, causing them to contract and push blood into the ventricles. It then funnels through a gateway called the AV node, which briefly delays the signal so the ventricles have time to fill, before the impulse races through a fast-conducting highway of specialized fibers and triggers both ventricles to squeeze together. The whole sequence takes less than a second and repeats tens of thousands of times a day without conscious effort.

Fibrillation disrupts this sequence at its root. Instead of one organized wavefront spreading across a chamber, the tissue develops multiple small electrical circuits spinning independently. Researchers describe these self-sustaining loops as “rotors,” spiraling waves of electrical activity that can anchor in one spot or drift unpredictably through the muscle. When a rotor stays put, you might see a fast but somewhat organized rhythm. When it fragments into many smaller wavelets, you get full-blown fibrillation.

Atrial Fibrillation and Where It Begins

Atrial fibrillation, commonly called AF or AFib, is the most common sustained heart rhythm disorder worldwide. It involves chaotic electrical activity confined to the upper chambers. Because the atria are smaller and contribute less pumping force than the ventricles, AF is not immediately life-threatening the way ventricular fibrillation is. But it carries serious long-term risks, and understanding where the chaotic signals originate has reshaped how doctors treat it.

A landmark discovery in the late 1990s showed that the sparks igniting most AF episodes come from the pulmonary veins, the vessels that carry oxygenated blood from the lungs into the left atrium. In one key study, nearly 89% of the ectopic beats that triggered AF originated from pulmonary veins.¹ These veins contain sleeves of heart muscle tissue that extend a short distance into the vessel wall, and these sleeves have slightly different electrical properties than the rest of the atrium, making them prone to firing off rogue impulses.²

Once those ectopic sparks reach atrial tissue, two things can sustain the fibrillation. The first is continued rapid firing from the pulmonary veins or other ectopic sites. The second is reentry, where electrical impulses loop back on themselves through the atrial tissue, finding pathways that let them circle again and again rather than dying out.³ Most people with AF have some combination of both mechanisms at work.

How Scar Tissue Feeds the Cycle

If the triggers come from the pulmonary veins, the fuel that keeps AF burning is often fibrosis, the gradual replacement of normal heart muscle with stiff scar-like tissue. Fibrosis is considered a hallmark of the structural changes that make AF harder to treat over time.⁴ Patches of fibrosis conduct electrical signals more slowly and unevenly than healthy muscle, creating the kind of zigzag pathways that allow reentrant circuits to form and persist.⁵

The troubling part is that AF itself promotes more fibrosis. Episodes of fibrillation stretch and stress atrial cells, triggering inflammatory and remodeling processes that lay down additional scar tissue. This creates a vicious cycle often summarized by the phrase “AF begets AF”: the longer someone has fibrillation, the more the atria remodel in ways that make fibrillation easier to sustain and harder to stop.⁶ This is why early intervention matters: a heart that has been fibrillating for years has a physically different substrate than one caught in its first episode.

Ventricular Fibrillation Is a Different Emergency

Ventricular fibrillation (VF) is the rhythm most people picture when they think of cardiac arrest. When the ventricles fibrillate, the heart’s main pumping chambers lose all coordinated contraction, and blood flow to the brain and organs stops within seconds. Without defibrillation, VF is fatal within minutes.

The electrical mechanism shares the same rotor concept as AF but plays out in tissue with different properties. A single rotor spinning in the ventricles can produce rapid but organized ventricular tachycardia (VT). If that rotor drifts or spins fast enough that the surrounding muscle cannot keep up one-to-one, wave fronts start breaking apart, and the rhythm degenerates from VT into the fragmented chaos of VF.⁷ This breakup into multiple competing wavelets is what makes VF so hard for the heart to escape on its own.

Research into what triggers wavebreak has identified the initial event as a premature beat or rapid burst of pacing that hits the tissue at just the wrong moment, creating a rotor. That rotor can anchor to scar tissue or a functional obstacle and stay as VT, or it can fragment further into VF depending on the heart’s underlying condition.⁸ Adrenaline surges can worsen this by amplifying certain calcium and potassium currents at different speeds, creating a temporary electrical imbalance that destabilizes a previously stable rotor.⁹

The Calcium Connection

At the cellular level, one of the key drivers of unstable heart rhythms is a phenomenon called alternans, where every other heartbeat produces a noticeably different electrical signal and calcium release. Researchers have shown that the root of this beat-to-beat seesaw lies in how heart cells handle calcium internally. In both atrial and ventricular cells, disturbances in the way calcium is released from internal stores and then pumped back produce alternating strong and weak contractions, which show up on an ECG as alternating long and short electrical signals.¹⁰

Alternans matters because it creates pockets of tissue that are electrically out of sync with their neighbors, setting the stage for wavebreak and reentry. In people with heart failure, this instability kicks in at slower heart rates than it does in healthy hearts, which helps explain why heart failure patients are more prone to dangerous rhythms even during moderate exertion.¹¹

Stroke Risk and Sluggish Blood

The most feared complication of atrial fibrillation is stroke. When the atria fibrillate instead of contracting properly, blood pools in a small pouch called the left atrial appendage. Sluggish flow in that appendage creates conditions where clots can form, and if a clot breaks free and travels to the brain, the result is an embolic stroke.¹²

More recent computational modeling has confirmed that people with AF who go on to have strokes tend to have measurably slower and more swirling blood flow in the left atrial appendage compared to AF patients who do not have strokes, even when the physical shape of the appendage looks the same between the two groups.¹³ This is why blood thinners remain a cornerstone of AF treatment: even if you cannot stop the fibrillation itself, preventing clots from forming reduces stroke risk dramatically.

Rate Control Versus Rhythm Control

For decades, doctors have debated two broad strategies for managing AF. Rate control accepts that the heart will keep fibrillating and uses medication to slow how fast the chaotic signals pass through to the ventricles, keeping the overall heart rate reasonable. Rhythm control tries to stop the fibrillation itself and restore normal sinus rhythm, using drugs, electrical cardioversion, or ablation procedures.

The AFFIRM trial, a large study from the early 2000s, found no survival advantage with rhythm control over rate control. In fact, the rhythm-control group had slightly more hospitalizations and drug side effects.¹⁴ That result surprised many cardiologists and led to a period where rate control was widely favored. More recent registry data from the era of newer blood thinners has largely confirmed the finding: after accounting for patient differences, the initial choice of rate versus rhythm control does not show a clear difference in the combined risk of death and blood clots.¹⁵

That said, rhythm control does appear to slow the progression of AF itself. One registry study found that patients managed with rhythm control were far less likely to progress from intermittent to persistent fibrillation.¹⁶ And newer trials focusing on early rhythm control (intervening within a year of diagnosis) have shifted opinion again toward more aggressive treatment, though the ideal strategy still depends on the individual patient’s symptoms, age, and other conditions.

Ablation and the Rise of Pulsed Field Energy

Catheter ablation for AF usually targets the pulmonary veins, deliberately scarring a ring of tissue around each vein’s opening to electrically isolate it from the rest of the atrium. If the triggers cannot reach the atrial muscle, they cannot start fibrillation.¹⁷ Traditional methods use either heat (radiofrequency energy) or extreme cold (cryotherapy) to create these lesions, and both work well but carry a small risk of collateral damage to nearby structures like the esophagus or the phrenic nerve.

A newer approach called pulsed field ablation (PFA) uses ultra-short bursts of electrical energy to punch tiny holes in cell membranes, a process called electroporation. Heart muscle cells are unusually sensitive to this kind of energy, so PFA can destroy them while largely sparing neighboring tissue types like nerve, esophageal, or blood vessel cells.¹⁸ A head-to-head trial comparing PFA with traditional thermal ablation found essentially identical one-year success rates, with roughly 73% of PFA patients and 71% of thermal ablation patients remaining free of recurrence.¹⁹

A meta-analysis pooling six comparative studies confirmed no significant difference in AF recurrence, vein isolation durability, or complication rates between PFA and thermal methods. The practical advantage of PFA was speed: procedures were about 20 minutes shorter on average.²⁰ For patients, shorter procedures generally mean less time under sedation and potentially faster recovery.

Defibrillation and How a Shock Resets the Heart

For ventricular fibrillation, the treatment is straightforward in concept if terrifying in practice: deliver a strong electric shock to the chest. The goal is to simultaneously depolarize enough of the heart muscle that all the competing wavefronts are extinguished at once, giving the sinus node a chance to reassert control. Biophysical modeling has identified two distinct ways this works at the cellular level, one involving mass excitation of resting cells and the other involving de-excitation of already-activated cells, with the mechanism depending on the shock’s strength and the electrical properties of the tissue.²¹

The first successful open-chest defibrillation of a human heart was performed in 1947. A decade later came closed-chest defibrillation, and the technology migrated from operating rooms to coronary care units, then to ambulances in the early 1970s, and finally into airports and shopping centers with the automated external defibrillators that laypeople can use today.²² The implantable cardioverter-defibrillator, which sits inside the body and shocks the heart automatically when it detects VF, arrived in 1980 and remains the standard of care for people at high risk of sudden cardiac death.

The Nervous System’s Role

The autonomic nervous system, the involuntary wiring that controls heart rate and digestion, plays a surprisingly large role in fibrillation. Both the sympathetic (“fight or flight”) and parasympathetic (“rest and digest”) branches can trigger AF under the right conditions. Clusters of nerve cells called ganglionated plexi sit on the surface of the atria and can fire bursts of activity that shorten atrial refractoriness and increase susceptibility to reentry.²³

Some people experience what clinicians call vagal AF, episodes triggered predominantly by the parasympathetic branch. These tend to occur at rest, after meals, or during sleep, rather than during exercise or stress.²⁴ The distinction matters practically because drugs that work well for exercise-triggered AF can sometimes worsen vagal AF, and vice versa. Recognizing the pattern helps doctors choose the right medication or ablation strategy.

Alcohol, Lifestyle, and the “Holiday Heart”

Binge drinking has long been recognized as a trigger for AF, a phenomenon sometimes called “holiday heart syndrome” because it was first noticed in otherwise healthy people showing up in emergency rooms after weekend celebrations. But the link goes beyond binge episodes. Even chronic moderate alcohol intake appears to raise AF risk through a combination of direct toxic effects on atrial cells and indirect contributions to other risk factors like obesity, high blood pressure, and sleep-disordered breathing.²⁵

Acutely, alcohol shortens the electrical refractory period in atrial tissue, slows conduction, increases ectopic firing, and tips the autonomic balance in ways that favor fibrillation. Over years, chronic use promotes the structural remodeling and fibrosis that create a lasting substrate for AF.²⁶ For people already diagnosed with AF, reducing or eliminating alcohol is one of the most impactful lifestyle changes available.

Inherited Conditions That Make Fibrillation More Likely

Most AF develops in older adults with hypertension, obesity, or structural heart disease. But a small fraction of cases are driven by inherited genetic mutations. The first gene linked to familial AF was KCNQ1, identified in a Chinese family with persistent AF spanning multiple generations. The mutation caused a gain of function in a potassium channel, shortening atrial refractoriness and making reentry easier to sustain.²⁷

On the ventricular side, conditions like long-QT syndrome and Brugada syndrome arise from mutations in ion channel genes that alter the heart’s electrical properties enough to predispose to life-threatening VT and VF, often at a young age.²⁸ Advances in molecular biology have made it possible to pinpoint these mutations and offer genetic testing to family members who might carry the same risk.²⁹ For carriers, an implantable defibrillator or targeted medication can be genuinely lifesaving.

Smartwatches and AI as Early Warning Systems

The idea of detecting fibrillation before someone has a stroke has driven a wave of consumer technology. A recent meta-analysis of 26 studies covering more than 17,000 patients found that smartwatches achieved about 95% sensitivity and 97% specificity for detecting AF, with individual device performance varying somewhat: Apple Watch around 94% sensitivity, Samsung devices around 97%, and the Withings ScanWatch around 89%.³⁰ These numbers sound impressive, and they are, but context matters: in a population where AF is rare (say, healthy 30-year-olds), even a 97% specificity means a lot of false alarms for every true case found.

An even more intriguing development is artificial intelligence that can detect signs of AF from an ECG recorded while the heart is in normal rhythm. AI models trained on standard 12-lead ECGs have achieved diagnostic accuracy scores in the range of 0.75 to 0.90 for flagging people with hidden or intermittent AF, and similar performance for predicting who will develop AF in the future.³¹ The AI appears to pick up subtle structural or electrical signatures in the heart’s normal rhythm that human eyes miss. If these tools can be integrated into routine screening, they could identify high-risk patients before a stroke serves as the first symptom.

When Fibrillation Starts Young

Fibrillation is not just a disease of aging. People born with structural heart defects develop AF at considerably younger ages than the general population. The risk is highest in those with conditions that chronically stretch or pressure the left atrium, such as left-sided obstructive lesions, pulmonary hypertension, or a surgically repaired Fontan circulation.³² Managing AF in these patients is more complicated than in the typical older adult because the heart’s anatomy has often been surgically altered, prior scarring can create additional reentrant circuits, and the long-term consequences of both the arrhythmia and its treatment accumulate over a much longer lifespan. Surgical approaches for AF in this population continue to evolve, aiming to restore sinus rhythm, improve the heart’s pumping efficiency, and reduce stroke risk while minimizing the need for repeat procedures.³³